NasdaqGS:PODDMedical Equipment
Is Insulet (PODD) Undervalued On Class I Recalls And Class Action Risk?
Insulet (PODD) has come under closer scrutiny after initiating multiple Class I recalls of its Omnipod insulin delivery devices, followed by securities class action filings that question the company’s disclosures around manufacturing controls and product safety.
See our latest analysis for Insulet.
After the Class I recalls and class action announcements, Insulet’s share price has been volatile, with a 12.55% 1 month share price return but a year to date share price return down 42.01%. The 1...